Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00542425 · ClinicalTrials.gov registry record · Phase 2
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
A Phase 2 study, sponsored by Radius Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 222
- Enrollment target
NCT00542425 is a Phase 2 study that has completed, run by Radius Health. The registered enrollment target is 222 participants.
The verdict
NCT00542425, a Phase 2 study, has completed, sponsored by Radius Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 222 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether BA058 is effective in building bone in postmenopausal women with osteoporosis.
Interventions
- DRUG Placebo
- DRUG teriparatide
- DRUG BA058 20 µg
- DRUG BA058 40 µg
- DRUG BA058 80 µg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2007-04 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00542425
The ClinicalTrials.gov registry entry for NCT00542425 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 222 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radius Health, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00542425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00542425 about?
NCT00542425 is a clinical study titled "Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis". The purpose of this study is to determine whether BA058 is effective in building bone in postmenopausal women with osteoporosis.
What is the current status of trial NCT00542425?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 222 participants. The study started on 2007-04. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00542425?
The interventions under investigation include: Placebo (DRUG), teriparatide (DRUG), BA058 20 µg (DRUG), BA058 40 µg (DRUG), BA058 80 µg (DRUG).
Who is sponsoring clinical trial NCT00542425?
This trial is sponsored by Radius Health, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.